Efficacy of First-Line Nivolumab Plus Ipilimumab in Unresectable Pleural Mesothelioma: A Multicenter Real-World Study (ImmunoMeso LATAM).

Autor: Enrico D; Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina. Electronic address: denrico@alexanderfleming.org., Gomez JE; Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina., Aguirre D; Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina., Tissera NS; Department of Medical Oncology, Upper Gastrointestinal and Endocrine Tumor Group, Vall´d Hebron Institute of Oncology (VHIO), Barcelona, Spain., Tsou F; Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina., Pupareli C; Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina., Tanco DP; Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina., Waisberg F; Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina., Rodríguez A; Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina., Rizzo M; Clinical Oncology Unit, Hospital Universitario Austral, Pilar Buenos Aires, Argentina; Laboratorio de Inmuno-biología del Cáncer, Instituto de Investigaciones en Medicina Traslacional, Universidad Austral-Consejo Nacional de Investigaciones Científicas y Tecnologicas (CONICET), Buenos Aires, Argentina., Minatta N; Clinical Oncology Unit, Hospital Universitario Austral, Pilar Buenos Aires, Argentina., Rafael P; Clinical Oncology Unit, Hospital Universitario Austral, Pilar Buenos Aires, Argentina., Basbus L; Departamento de Oncología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Lupinacci L; Departamento de Oncología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Kaen D; Departamento de Oncología, Hospital de Clínicas Virgen María de Fátima, National University of La Rioja, La Rioja, Argentina., Ramos M; Departamento de Oncología, Hospital Alemán, Buenos Aires, Argentina., Bluthgen V; Departamento de Oncología, Hospital Alemán, Buenos Aires, Argentina., Castagneris N; Medical Oncology Unit, Reina Fabiola University Clinic, Universidad Católica de Córdoba, Córdoba, Argentina., Coppola MP; Departamento de Oncología, Hospital Zonal Especializado en Agudos y Crónicos Dr. Antonio Cetrangolo, Buenos Aires, Argentina., Scocimarro A; Departamento de Oncología, Hospital Zonal Especializado en Agudos y Crónicos Dr. Antonio Cetrangolo, Buenos Aires, Argentina., Guerra MF; Departamento de Oncología, Angel Roffo Oncology Institute, Universtiy of Buenos Aires, Buenos Aires, Argentina., Perfetti A; Department of Medical Oncology, Center for Medical Education and Clinical Research Norberto Quirno (CEMIC), Buenos Aires, Argentina., Levit P; Department of Medical Oncology, Unión Personal-Accord Salud, Buenos Aires, Argentina., Galvez-Nino M; Clinical Research Unit, Auna Ideas, Lima, Perú., Mas L; Department of Medical Oncology, Oncosalud - Auna, Lima, Perú; Latin American Cansortium for Lung Cancer Research., Rojas L; Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center - CTIC, Direction of Research and Education/Thoracic Oncology Functional Unit, Bogotá, Colombia., Zuluaga J; Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center - CTIC, Direction of Research and Education/Thoracic Oncology Functional Unit, Bogotá, Colombia., Chacón M; Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina., Corrales L; Departamento de Oncología, Centro de Investigación y Manejo del Cáncer (CIMCA), San José, Costa Rica; Latin American Cansortium for Lung Cancer Research., Samtani S; Departamento de Oncología, Clínica Las Condes Santiago, Las Condes, Chile., Arrieta O; Departamento de Oncología, Instituto Nacional de Cancerología (INCan), México City, México; Latin American Cansortium for Lung Cancer Research., Cardona A; Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center - CTIC, Direction of Research and Education/Thoracic Oncology Functional Unit, Bogotá, Colombia; Latin American Cansortium for Lung Cancer Research., Remon J; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Martín C; Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina; Latin American Cansortium for Lung Cancer Research.

Publikováno v: Clinical lung cancer [Clin Lung Cancer] 2024 Dec; Vol. 25 (8), pp. 723-731.e2. Date of Electronic Publication: 2024 Sep 21.